Search research articles
Contact Us
Filters
Showing results (111-120 of 179) with videos related to
Page
of 18
Sort By:
Clinical Chemistry
|
January 24, 2002
Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline
Hubert W Vesper, Laurence M Demers, Richard Eastell, et al.
Current Medical Research and Opinion
|
May 4, 2004
Efficacy of risedronate on clinical vertebral fractures within six months
Christian Roux, Ego Seeman, Richard Eastell, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
November 6, 2019
Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone Diseases
E Michael Lewiecki, John P Bilezikian, Risa Kagan, et al.
Bone
|
January 9, 2020
History of etidronate
Nelson B Watts, Charles H Chesnut, Harry K Genant, et al.
JAMA Network Open
|
March 18, 2025
Identifying Younger Postmenopausal Women With Osteoporosis Using USPSTF-Recommended Osteoporosis Risk Assessment Tools
Henry W Zheng, Alex A T Bui, Kristine E Ensrud, et al.
Diabetologia
|
August 11, 2019
Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program
Zien Zhou, Meg Jardine, Vlado Perkovic, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 19, 2014
Associations of menopausal vasomotor symptoms with fracture incidence
Carolyn J Crandall, Aaron Aragaki, Jane A Cauley, et al.
Current Medical Research and Opinion
|
April 7, 2005
Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE
Charles H Chesnut, Mark P Ettinger, Paul D Miller, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 10, 2017
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension
Nelson B Watts, Jacques P Brown, Socrates Papapoulos, et al.
Southern Medical Journal
|
March 13, 2009
Management of osteoporosis among home health and long-term care patients with a prior fracture
Amy H Warriner, Ryan C Outman, Kenneth G Saag, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 179) with videos related to
Sort By:
Page
of 18
Clinical Chemistry
|
January 24, 2002
Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyridinoline
Hubert W Vesper, Laurence M Demers, Richard Eastell, et al.
Current Medical Research and Opinion
|
May 4, 2004
Efficacy of risedronate on clinical vertebral fractures within six months
Christian Roux, Ego Seeman, Richard Eastell, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry
|
November 6, 2019
Proceedings of the 2019 Santa Fe Bone Symposium: New Concepts in the Care of Osteoporosis and Rare Bone Diseases
E Michael Lewiecki, John P Bilezikian, Risa Kagan, et al.
Bone
|
January 9, 2020
History of etidronate
Nelson B Watts, Charles H Chesnut, Harry K Genant, et al.
JAMA Network Open
|
March 18, 2025
Identifying Younger Postmenopausal Women With Osteoporosis Using USPSTF-Recommended Osteoporosis Risk Assessment Tools
Henry W Zheng, Alex A T Bui, Kristine E Ensrud, et al.
Diabetologia
|
August 11, 2019
Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program
Zien Zhou, Meg Jardine, Vlado Perkovic, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 19, 2014
Associations of menopausal vasomotor symptoms with fracture incidence
Carolyn J Crandall, Aaron Aragaki, Jane A Cauley, et al.
Current Medical Research and Opinion
|
April 7, 2005
Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE
Charles H Chesnut, Mark P Ettinger, Paul D Miller, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 10, 2017
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension
Nelson B Watts, Jacques P Brown, Socrates Papapoulos, et al.
Southern Medical Journal
|
March 13, 2009
Management of osteoporosis among home health and long-term care patients with a prior fracture
Amy H Warriner, Ryan C Outman, Kenneth G Saag, et al.
Page
of 18